home / stock / adxs / adxs short
Short Information | Advaxis (NASDAQ:ADXS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 13,698,318 |
Total Actual Volume | 69,998,949 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 684,916 |
Average Short Percentage | 19.56% |
Is there a ADXS Short Squeeze or Breakout about to happen?
See the ADXS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
12-22-2021 | $0.29 | $0.24 | $0.2902 | $0.2356 | 11,640,473 | 1,546,604 | 13.29% |
12-21-2021 | $0.3033 | $0.2943 | $0.3033 | $0.287 | 3,165,617 | 680,882 | 21.51% |
12-20-2021 | $0.32 | $0.2962 | $0.32 | $0.2746 | 3,752,751 | 784,883 | 20.91% |
12-17-2021 | $0.3204 | $0.325 | $0.328 | $0.305 | 2,379,154 | 299,470 | 12.59% |
12-15-2021 | $0.3 | $0.3174 | $0.3245 | $0.293 | 1,714,019 | 458,576 | 26.75% |
12-14-2021 | $0.3126 | $0.309 | $0.3299 | $0.3 | 2,765,718 | 845,020 | 30.55% |
12-13-2021 | $0.3159 | $0.3126 | $0.33 | $0.3045 | 1,798,014 | 352,127 | 19.58% |
12-10-2021 | $0.3718 | $0.325 | $0.377 | $0.32 | 3,015,216 | 892,258 | 29.59% |
12-09-2021 | $0.3692 | $0.3478 | $0.382 | $0.347 | 2,360,508 | 360,425 | 15.27% |
12-08-2021 | $0.343 | $0.36 | $0.366 | $0.3398 | 1,672,367 | 88,699 | 5.3% |
12-07-2021 | $0.3538 | $0.3544 | $0.3799 | $0.35 | 2,844,696 | 207,966 | 7.31% |
12-06-2021 | $0.3134 | $0.3445 | $0.348 | $0.3013 | 2,738,762 | 456,561 | 16.67% |
12-01-2021 | $0.37 | $0.3444 | $0.3725 | $0.3302 | 3,256,281 | 796,957 | 24.47% |
11-30-2021 | $0.4 | $0.37 | $0.41 | $0.365 | 3,299,557 | 670,515 | 20.32% |
11-29-2021 | $0.3902 | $0.4002 | $0.42 | $0.3622 | 8,359,562 | 1,836,043 | 21.96% |
11-26-2021 | $0.3763 | $0.3847 | $0.3897 | $0.365 | 1,656,652 | 342,388 | 20.67% |
11-24-2021 | $0.3665 | $0.4017 | $0.4199 | $0.36 | 5,426,460 | 1,499,010 | 27.62% |
11-23-2021 | $0.3796 | $0.3621 | $0.3796 | $0.3501 | 1,868,892 | 293,011 | 15.68% |
11-22-2021 | $0.3807 | $0.368 | $0.3886 | $0.3508 | 3,302,961 | 613,494 | 18.57% |
11-19-2021 | $0.379 | $0.3772 | $0.3902 | $0.37 | 2,981,289 | 673,429 | 22.59% |
News, Short Squeeze, Breakout and More Instantly...
MONMOUTH JUNCTION, N.J., March 26, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced the completion of the previously announced sale of AL102, and related drug candidate AL101, to Immunome, Inc. (Nasdaq: IMNM). As per the ...
REHOVOT, Israel and MONMOUTH JUNCTION, N.J., Feb. 20, 2024 (GLOBE NEWSWIRE) -- Ayala Pharmaceuticals, Inc. (OTCQX: ADXS), a clinical-stage oncology company, today announced that patient enrollment has been completed in the Phase 3 RINGSIDE study evaluating AL102 in desmoid tumors. A total of 156 ...
International Zeolite Corp. (IZCFF) is expected to report for Q2 2024 International Stem Cell Corporation (ISCO) is expected to report for Q4 2023 Zivo Bioscience Inc. (ZIVO) is expected to report for Q4 2023 Hongchang International Co Ltd Com (New) (HCIL) is expected to report for Q4...